YCBD Stock Overview
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
cbdMD, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.91 |
| 52 Week High | US$5.24 |
| 52 Week Low | US$0.56 |
| Beta | 2.09 |
| 1 Month Change | 0.011% |
| 3 Month Change | 12.92% |
| 1 Year Change | -78.91% |
| 3 Year Change | -99.47% |
| 5 Year Change | -99.66% |
| Change since IPO | -99.30% |
Recent News & Updates
Recent updates
cbdMD (NYSEMKT:YCBD) Has Debt But No Earnings; Should You Worry?
Mar 23
This Insider Has Just Sold Shares In cbdMD, Inc. (NYSEMKT:YCBD)
Feb 23If You Had Bought cbdMD (NYSEMKT:YCBD) Stock A Year Ago, You Could Pocket A 383% Gain Today
Feb 09We Wouldn't Rely On cbdMD's (NYSEMKT:YCBD) Statutory Earnings As A Guide
Jan 13Is cbdMD (NYSEMKT:YCBD) Using Debt Sensibly?
Dec 15
Shareholder Returns
| YCBD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -1.1% | 0.9% | 1.2% |
| 1Y | -78.9% | 13.9% | 24.7% |
Return vs Industry: YCBD underperformed the US Pharmaceuticals industry which returned 13.9% over the past year.
Return vs Market: YCBD underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| YCBD volatility | |
|---|---|
| YCBD Average Weekly Movement | 13.1% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: YCBD's share price has been volatile over the past 3 months.
Volatility Over Time: YCBD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 52 | T. Kennedy | www.cbdmd.com |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.
cbdMD, Inc. Fundamentals Summary
| YCBD fundamental statistics | |
|---|---|
| Market cap | US$2.77m |
| Earnings (TTM) | -US$23.98m |
| Revenue (TTM) | US$23.45m |
0.1x
P/S Ratio-0.1x
P/E RatioIs YCBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YCBD income statement (TTM) | |
|---|---|
| Revenue | US$23.45m |
| Cost of Revenue | US$8.48m |
| Gross Profit | US$14.97m |
| Other Expenses | US$38.95m |
| Earnings | -US$23.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.88 |
| Gross Margin | 63.84% |
| Net Profit Margin | -102.28% |
| Debt/Equity Ratio | 0% |
How did YCBD perform over the long term?
See historical performance and comparison